Bene probably have manufacturing or utility patents around the whole process, so even if one or more of their scientists jumped ship and took all the IP with them they couldn’t just set up a new facility and start churning it out (even though the product itself is long out of patent).
Or to put it another way, even if some sort of IA application told you exactly how Bene created this molecule, you probably couldn’t replicate the process without infringing one or more of Bene’s patents.
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-221
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.015(6.12%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $17.07K | 67.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 20609 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 21438 | 4 |
View Market Depth
| Last trade - 12.44pm 01/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |